Traditionally, breast cancers are classified according to histology, tumor size, lymph node status, histological grade, and the biomarkers ER (estrogen receptor), PR (progesterone receptor), and human epidermal growth factor receptor 2 (HER2) status, which are universally recommended [2]. This evidence concerns the gene ESR1 and breast cancer.